Funded opportunities

Please read the studentship adverts for eligibility criteria, funding and application process.

Population Health Sciences (NIHR BRC funded): Using physical activity and physical function metrics to develop a ‘movement age’ in those with multiple long-term conditions (MLTCs)

• Supervisor: Dr Joe Henson
• Start date: 22 September 2025
• Closing date: 31 March 2025

Leicester Institute for Structural and Chemical Biology: PhD in Molecular and Cell Biology

• 4 projects to select from
• Start date: September 2025
• Closing date: 30 March 2025

Cancer Studies: A multimodal fine-funded foundation model to support precision medicine of mesothelioma

• Open to UK applicants only
• Supervisors: Professor Dean Fennell, Professor Hiuyu Zhou, Professor Hongyi Yang
• Start date: 1 October 2025
• Closing date: 10 April 2025

Molecular and Cell Biology PhD for January 2025 Master's students

• Available for 2026 entry for students who register on the University of Leicester Master's MSc Cancer Cell and Molecular Biology or MSc Molecular Genetics January 2025 intake.

Self funded projects

Open to overseas applicants who can fund their own study or hold their own external sponsorship. For further information about the available projects please click on the subject page links.

Projects open until filled unless stated

Population Health Sciences 

• Dr Sharmin Shabnam: Personalising thresholds of risk factor control for prevention of cardiovascular disease in subjects with diabetes
• Dr Dimitrios Papamargaritis: Harnessing mechanistic technologies and real-world clinical data to advance the interdisciplinary field of obesity and cancer prevention
• Dr Rupert Major: Patient support for decision making in relation to arterio-venous fistula formation before dialysis and ligation after a successful transplant: a mixed-methods study (open to UK and overseas)

Respiratory Sciences

• Dr John E. Pearl: Survey of clinical non-tuberculous mycobacteria isolates for mycobacteriophages: their presence, diversity and potential role in disease
• Dr Natalie Garton: Rhodococcus equi lipid bodies: Targeting the pathogen’s fat reserves for infection control
• Professor Andrea Cooper: Stratification of TB risk by immunophenotyping and expression of key diagnostic markers
• Professor Galina Mukamolova: Development of novel therapeutic strategies to target Mycobacterium tuberculosis virulence

Healthcare

• Professor Joseph Manning: Reducing pressure injury in critically Ill hospitalised infants, children and young people: An intervention bundle development and feasibility testing study
• Professor Debi Bhattacharya: Development and evaluation of a theory and evidence-based model for normalising Self-Administration of Medicines (SAM) in hospital
• Professor Joseph Manning: Paediatric to Adult intenSive care tranSition for chronicAlly critically ill younG pEople: The PASSAGE Study
• Dr Linda Birt: Advance care planning conversations in care home, understanding resident and family experiences
• Dr Sion Scott: An intervention to facilitate deprescribing for people with intellectual disability